• OPEN AN ACCOUNT
Indian Indices
Sensex
78,581.00 152.05
( 0.19%)
Global Indices
Nasdaq
54,113.09 913.68
(1.72%)
Dow Jones
7,758.57 137.07
(1.80%)
Hang Seng
66,265.57 2,308.04
(3.61%)
Nikkei 225
10,894.52 15.14
(0.14%)
Forex
USD-INR
95.29 -0.10
(-0.11%)
EUR-INR
109.78 -0.22
(-0.20%)
GBP-INR
128.18 -0.43
(-0.33%)
JPY-INR
0.61 0.00
(0.31%)

EQUITY - MARKET SCREENER

Nirman Agri Genetics Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
78482
INE0OK701014
159.2444888
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NIRMAN
1.68
29.6
EPS(TTM)
Face Value()
Div & Yield %
21.98
10
0
 

InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.